Wells Fargo
CLBT icon

Wells Fargo’s Cellebrite CLBT Stock Holding History

Wells Fargo’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$996K Buy
68,190
+7,213
+12% +$95.3K ﹤0.01% 4110
2026
Q1 		$840K Buy
60,977
+5,313
+10% +$80.1K ﹤0.01% 3838
2025
Q4 		$1M Sell
55,664
-6,847
-11% -$123K ﹤0.01% 3969
2025
Q3 		$1.16M Buy
62,511
+15,004
+32% +$236K ﹤0.01% 3712
2025
Q2 		$760K Buy
47,507
+3,540
+8% +$63.1K ﹤0.01% 3868
2025
Q1 		$854K Sell
43,967
-10,759
-20% -$226K ﹤0.01% 3752
2024
Q4 		$1.21M Buy
54,726
+23,688
+76% +$456K ﹤0.01% 3570
2024
Q3 		$523K Buy
+31,038
New +$461K ﹤0.01% 3966
2024
Q1 		– Sell
-1,700
Closed -$14.7K – 7523
2023
Q4 		$14.7K Buy
+1,700
New +$13.2K ﹤0.01% 5727

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Wells Fargo's CLBT Position: Q2 2026 in Review

Wells Fargo increased its Cellebrite (CLBT) stake by 12% in Q2 2026, buying an estimated $95.3K and bringing the position to 68,190 shares worth $996K. The position accounts for ﹤0.01% of the portfolio, ranked #4110.

Wells Fargo first reported a position in CLBT in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.21M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Wells Fargo held 68,190 shares of Cellebrite worth $996K as of Q2 2026.
  • Wells Fargo bought 7,213 Cellebrite shares in Q2 2026, an estimated $95.3K.
  • Cellebrite made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4110 holding.
  • Wells Fargo first reported a position in Cellebrite in Q4 2023 and has held it in 9 quarters since.
  • Wells Fargo's Cellebrite position peaked at $1.21M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.